Green Cross induced 100 million dollars of foreign capitals.

Published: 2000-03-07 11:15:00

Updated: 2000-03-07 11:15:00

Green Cross made a strategic business tie-up with Rhein Biotech NV, a German multinational bio-engineering company and took a signature ceremony between Mr. Cho Ung-joon, the vice president of Green Cross and Dr. Daan Ellens, the CEO of Rhein Biotech at Maastricht in Netherland on March 1.

Gre...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK